Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.
暂无分享,去创建一个
E. Ohman | S. Hazen | M. Farkouh | J. Parrillo | K. Ramanathan | J. Webb | C. Buller | W. Cantor | J. Alexander | J. Hochman | R. Harrington | D. Holmes | Z. Vered | J. Panza | N. Kleiman | D. Hathaway | V. Džavík | A. Stebbins | D. Baran | G. Cotter | S. Gross | H. Reynolds | R. Prondzinsky
[1] H. White,et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. , 2006, JAMA.
[2] L. Sleeper,et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. , 2005, Archives of internal medicine.
[3] J. Bakker,et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock* , 2004, Critical care medicine.
[4] F. Recchia. Role of Nitric Oxide in the Regulation of Substrate Metabolism in Heart Failure , 2002, Heart Failure Reviews.
[5] Z. Vered,et al. LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. , 2003, European heart journal.
[6] J. Hochman,et al. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. , 2003, Circulation.
[7] Z. Shun,et al. Dunnett's Many-to-One Test and Least Square Means , 2003, Journal of biopharmaceutical statistics.
[8] L. Parsons,et al. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). , 2002, Journal of the American College of Cardiology.
[9] O. Binah,et al. Role of Myocardial Inducible Nitric Oxide Synthase in Contractile Dysfunction and &bgr;-Adrenergic Hyporesponsiveness in Rats With Experimental Volume-Overload Heart Failure , 2002, Circulation.
[10] R. Kerber,et al. Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model. , 2001, Journal of the American College of Cardiology.
[11] H. White,et al. One-year survival following early revascularization for cardiogenic shock. , 2001, JAMA.
[12] M. Picard,et al. Congenital Deficiency of Nitric Oxide Synthase 2 Protects Against Endotoxin-Induced Myocardial Dysfunction in Mice , 2000, Circulation.
[13] H. White,et al. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. , 2000, The American journal of medicine.
[14] Z. Vered,et al. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock. , 2000, Circulation.
[15] L. Viera,et al. Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. , 1999, Free radical biology & medicine.
[16] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.
[17] B. Reichart,et al. Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischemia and reperfusion--implications for iNOS-mediated myocardial stunning. , 1999, The Thoracic and cardiovascular surgeon.
[18] L. Sleeper,et al. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group. , 1999, American heart journal.
[19] A. Takeshita,et al. Role of Myocyte Nitric Oxide in β-Adrenergic Hyporesponsiveness in Heart Failure , 1997 .
[20] J. Parrillo,et al. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. , 1993, The American journal of physiology.
[21] A. Takeshita,et al. Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure. , 1997, Circulation.
[22] B. Reichart,et al. S-methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction. , 1996, Biochemical and biophysical research communications.
[23] J. Zimmerberg,et al. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. , 1993, The American journal of physiology.
[24] Simon C Watkins,et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.
[25] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.